Definitive Contract 75N93023C00031
Award Date
9/30/23
Potential Completion Date
9/29/25
Potential Value
$600K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Pop Biotechnologies Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Buffalo, NY 14228, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $599,897 firm fixed price definitive contract between the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) and Pop Biotechnologies Inc., a Buffalo, NY-based biotechnology company. The objective of this Small Business Innovation Research (SBIR) Program Phase I contract is for Pop Biotechnologies to utilize a next-generation vaccine adjuvant to induce rapid and serum-stable spontaneous...
This federal contract award to Protein Sciences Corp, a for-profit manufacturer, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS). The $14,675 firm-fixed-price purchase order is for the provision of tested influenza virus proteins. The contract does not have a set-aside designation. Protein Sciences has received multiple previous federal contract awards from the HHS Office of the Assistant Secretary...
This federal contract award to Protein Sciences Corp from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, is for the research and development of a protein antigen in support of pandemic influenza preparedness and response. The contract has a Firm Fixed Price of $6,425.00 and was designated as a Total Small Business set-aside. Protein Sciences Corp, a for-profit manufacturer, has received multiple prior contract...
This is a $224,981.00 firm-fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Epitogenesis Inc., a minority-owned, economically disadvantaged women-owned small business. The contract is for the development of "A NUTRITIVE VACCINE ADJUVANT AGAINST INFLUENZA" and has a period of performance ending on September 14, 2015. The contract was set aside for small businesses.
This is a $37,000 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Protein Sciences Corp, a for-profit manufacturer, to provide purified recombinant proteins. The contract has no set-aside designation. Protein Sciences Corp has received multiple federal contract awards from HHS's Office of the Assistant Secretary for Preparedness and Response...
The Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $599,980 firm fixed price contract to Tendel Therapies, Inc., a small business, for research and development services related to genetic adjuvants to promote durable anti-influenza stem antibodies in older adults. This contract was awarded under the NIH and Centers for Disease Control and Prevention's Small Business Innovation Research (SBIR) program,...
This is a federal contract award to Protein Sciences Corp, a for-profit manufacturer, by the National Institute of Allergy and Infectious Diseases (NIAID) within the Department of Health and Human Services (HHS). The $33,250.00 fixed-price level of effort contract is for the procurement of TAS::75 0885::TAS IV P55, 1MG ALIQUOT, CAT # 3005, LOT # 1032-145, with a completion date of June 25, 2010. The contract is not designated as a set-aside. Protein Sciences provides specialized pandemic...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Fraunhofer USA, Inc. for the development of influenza virus-like particles in a plant-based system. The contract has a ceiling value of $364,793 and a period of performance that ends on March 29, 2017. The contract was not set aside for a specific business type. Fraunhofer USA, Inc. is the...
This is a $600,000.00 Firm Fixed Price contract awarded by the National Institutes of Health (NIH), part of the Department of Health and Human Services (HHS), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The objective is to develop an effective human immunodeficiency virus (HIV) vaccine using engineered nanoparticles loaded with messenger RNA (mRNA) targeted to antigen presenting cells. This contract is part of the Small Business Innovation Research (SBIR)...
This contract award to Protein Sciences Corp. is for the provision of custom proteins for influenza research. The $22,362.50 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, which is part of the U.S. Department of Health and Human Services. The work will be performed at Protein Sciences' facility in Meriden, Connecticut. Protein Sciences is a for-profit manufacturer that has received multiple prior contract awards from the Office of the...